Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 05'th May 2026
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™
06:59am, Monday, 04'th May 2026
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026™.
Bristol-Myers Squibb: The CAR-T Giant The Market Is Undervaluing
03:20am, Saturday, 02'nd May 2026
Bristol Myers Squibb faces a major patent cliff but is well-equipped with a robust pipeline and significant CAR-T optionality. BMY trades at a discounted 9.4x forward P/E, reflecting patent cliff fear
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Friday, 01'st May 2026
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Why Bristol Myers Squibb Stock Rocked the Market Today
04:17pm, Thursday, 30'th Apr 2026
It scored crushing beats on both revenue and profitability in its first quarter.
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call Transcript
03:51pm, Thursday, 30'th Apr 2026
Bristol-Myers Squibb Company (BMY) Q1 2026 Earnings Call Transcript
Why Is Bristol-Myers Squibb Stock Trading Higher On Thursday?
02:12pm, Thursday, 30'th Apr 2026
Bristol-Myers Squibb Co. (NYSE:BMY) shares are up on Thursday as the company reported its first-quarter financial results for 2026.
BMY's Q1 Earnings Top Estimates, Breyanzi, Camzyos Drive Sales
11:30am, Thursday, 30'th Apr 2026
Bristol-Myers beats Q1 estimates as strong Growth Portfolio sales and Eliquis demand offset legacy drug declines.
Bristol Myers (BMY) Reports Q1 Earnings: What Key Metrics Have to Say
11:01am, Thursday, 30'th Apr 2026
The headline numbers for Bristol Myers (BMY) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street est
Bristol Myers Squibb (BMY) Tops Q1 Earnings and Revenue Estimates
09:30am, Thursday, 30'th Apr 2026
Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.58 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings of $1.8 per share a year ago.
Bristol Myers Squibb (BMY) Q1 2026: EPS $1.31 Beats $1.19 Est., Revenue $11.49B Tops $10.91B -- Is It 4.8% Overvalued? GF Score 79/100
07:33am, Thursday, 30'th Apr 2026
Q1 2026 revenue was $11.49 billion. The estimated revenue was $10.91 billion.GAAP EPS was $1.31. The estimated EPS was $1.19.Non-GAAP EPS was $1.58. The estima
Breakfast News: Alphabet CEO Hails AI Capex Payoff
07:30am, Thursday, 30'th Apr 2026
GOOG sees results from AI investments, Fed meeting reveals growing divisions, and more
Bristol Myers Squibb Logs Higher Sales, Profit
07:11am, Thursday, 30'th Apr 2026
Bristol Myers Squibb posted higher first-quarter revenue boosted by its portfolio of newer treatments for heart and blood conditions.
Bristol Myers posts higher-than-expected quarterly profit on blood thinner, cancer sales
07:01am, Thursday, 30'th Apr 2026
Bristol Myers Squibb reported a first-quarter profit that beat Wall Street expectations on Thursday, helped by better-than-expected growth of blood thinner Eliquis as well as newer cancer medicines
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
06:59am, Thursday, 30'th Apr 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Reports First Quarter Financial Results for 2026.
